Search research articles
Contact Us
Filters
Showing results (101-110 of 231) with videos related to
Page
of 24
Sort By:
Nanoscale
|
October 7, 2024
Oxidation-induced modulation of photoresponsivity in monolayer MoS<sub>2</sub> with sulfur vacancies
Irfan H Abidi, Ankit Bhoriya, Pargam Vashishtha, et al.
Lancet (London, England)
|
December 27, 2016
Bortezomib with lenalidomide and dexamethasone versus lenalidomide and dexamethasone alone in patients with newly diagnosed myeloma without intent for immediate autologous stem-cell transplant (SWOG S0777): a randomised, open-label, phase 3 trial
Brian G M Durie, Antje Hoering, Muneer H Abidi, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
February 2, 2016
Targeting CD138-/CD20+ Clonogenic Myeloma Precursor Cells Decreases These Cells and Induces Transferable Antimyeloma Immunity
Lawrence G Lum, Archana Thakur, Sri Vidya Kondadasula, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
April 18, 2020
Low-dose versus High-dose Carfilzomib with Dexamethasone (S1304) in Patients with Relapsed-Refractory Multiple Myeloma
Sikander Ailawadhi, Rachael Sexton, Suzanne Lentzsch, et al.
Blood
|
September 30, 2018
Five-year PFS from the AETHERA trial of brentuximab vedotin for Hodgkin lymphoma at high risk of progression or relapse
Craig H Moskowitz, Jan Walewski, Auayporn Nademanee, et al.
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases
|
July 17, 2024
Ciprofloxacin versus levofloxacin prophylaxis in hematopoietic stem cell transplantation: A randomized trial
Shatha Farhan, Izabela Mazur, Susan Hartzell, et al.
Blood Cancer Journal
|
May 13, 2020
Longer term follow-up of the randomized phase III trial SWOG S0777: bortezomib, lenalidomide and dexamethasone vs. lenalidomide and dexamethasone in patients (Pts) with previously untreated multiple myeloma without an intent for immediate autologous stem cell transplant (ASCT)
Brian G M Durie, Antje Hoering, Rachael Sexton, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
March 27, 2013
CD20-targeted T cells after stem cell transplantation for high risk and refractory non-Hodgkin's lymphoma
Lawrence G Lum, Archana Thakur, Qin Liu, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
June 23, 2009
Clinical and ultrasonic evaluation of spleen size during peripheral blood progenitor cell mobilization by filgrastim: results of an open-label trial in normal donors
Patrick J Stiff, William Bensinger, Muneer H Abidi, et al.
BMJ Open
|
March 28, 2020
Investigation of an extensive outbreak of HIV infection among children in Sindh, Pakistan: protocol for a matched case<b>-</b>control study
Amna R Siddiqui, Apsara Ali Nathwani, Syed H Abidi, et al.
Page
of 24
Search research articles
Search
Showing results (101-110 of 231) with videos related to
Sort By:
Page
of 24
Nanoscale
|
October 7, 2024
Oxidation-induced modulation of photoresponsivity in monolayer MoS<sub>2</sub> with sulfur vacancies
Irfan H Abidi, Ankit Bhoriya, Pargam Vashishtha, et al.
Lancet (London, England)
|
December 27, 2016
Bortezomib with lenalidomide and dexamethasone versus lenalidomide and dexamethasone alone in patients with newly diagnosed myeloma without intent for immediate autologous stem-cell transplant (SWOG S0777): a randomised, open-label, phase 3 trial
Brian G M Durie, Antje Hoering, Muneer H Abidi, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
February 2, 2016
Targeting CD138-/CD20+ Clonogenic Myeloma Precursor Cells Decreases These Cells and Induces Transferable Antimyeloma Immunity
Lawrence G Lum, Archana Thakur, Sri Vidya Kondadasula, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
April 18, 2020
Low-dose versus High-dose Carfilzomib with Dexamethasone (S1304) in Patients with Relapsed-Refractory Multiple Myeloma
Sikander Ailawadhi, Rachael Sexton, Suzanne Lentzsch, et al.
Blood
|
September 30, 2018
Five-year PFS from the AETHERA trial of brentuximab vedotin for Hodgkin lymphoma at high risk of progression or relapse
Craig H Moskowitz, Jan Walewski, Auayporn Nademanee, et al.
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases
|
July 17, 2024
Ciprofloxacin versus levofloxacin prophylaxis in hematopoietic stem cell transplantation: A randomized trial
Shatha Farhan, Izabela Mazur, Susan Hartzell, et al.
Blood Cancer Journal
|
May 13, 2020
Longer term follow-up of the randomized phase III trial SWOG S0777: bortezomib, lenalidomide and dexamethasone vs. lenalidomide and dexamethasone in patients (Pts) with previously untreated multiple myeloma without an intent for immediate autologous stem cell transplant (ASCT)
Brian G M Durie, Antje Hoering, Rachael Sexton, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
March 27, 2013
CD20-targeted T cells after stem cell transplantation for high risk and refractory non-Hodgkin's lymphoma
Lawrence G Lum, Archana Thakur, Qin Liu, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
June 23, 2009
Clinical and ultrasonic evaluation of spleen size during peripheral blood progenitor cell mobilization by filgrastim: results of an open-label trial in normal donors
Patrick J Stiff, William Bensinger, Muneer H Abidi, et al.
BMJ Open
|
March 28, 2020
Investigation of an extensive outbreak of HIV infection among children in Sindh, Pakistan: protocol for a matched case<b>-</b>control study
Amna R Siddiqui, Apsara Ali Nathwani, Syed H Abidi, et al.
Page
of 24